25th Jun 2021 14:28
RTW Venture Fund Ltd - investment company focused on the life sciences sector - Investee company Monte Rosa Therapeutics completes USD222.3 million initial public offering on the Nasdaq. Monte Rosa describes itself as a biotechnology company developing small molecule degraders to eliminate disease-causing proteins.
Monte Rosa's IPO raised USD222.3 million by placing 11.7 million shares at USD19.00 each. On the first day of trading, Monte Rosa's share price rose 12% to close at USD21.18 per share.
Prior to the IPO, RTW took part in Monte Rosa's USD95 million series C financing round in March.
Current stock price: USD1.94
Year-to-date change: up 3.4%
By Will Paige; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Rtw Biotech